Some patients with incurable tumors and BRCA mutations respond to new 2-drug combination

Dana-Farber scientists find when given together, two orally available experimental drugs — sapacitabine and seliciclib — worked together to elicit antitumor effects in patients with incurable BRCA-deficient cancers.

Fuente : http://www.eurekalert.org/pub_releases/2013-04/dci…